Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 13Breast Neoplasms 13Colorectal Neoplasms 8Obesity 7Ovarian Neoplasms 6Motor Activity 5Malnutrition 5Rectal Neoplasms 4Polycystic Ovary Syndrome 4Pancreatic Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Radiation Injuries 3Overweight 3Multiple Myeloma 3Melanoma 3Lung Neoplasms 3Gastrointestinal Neoplasms 3Colonic Neoplasms 3Weight Loss 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Insulin Resistance 2Head and Neck Neoplasms 2Glioblastoma 2

Interventions

Exercise 3Metformin 2Megestrol Acetate 2Yoga 1Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination 1Sitagliptin Phosphate 1Resistance Training 1Radiotherapy, Intensity-Modulated 1Professional Autonomy 1Prebiotics 1Nutrition Assessment 1Motivational Interviewing 1Mirtazapine 1Magnetic Resonance Spectroscopy 1Hematologic Tests 1Doxorubicin 1Dietary Supplements 1Diet Therapy 1Diet 1Cyclophosphamide 1Cisplatin 1Caseins 1Caloric Restriction 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Body Weight × Diet Therapy × Clear all
NCT01482286 2022-03-15

PULSE

Pennington Biomedical Research Center

Phase 3 Terminated
32 enrolled 10 charts

Body Weight, Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡